|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Glaucoma | |||||
| Trabeculectomy | |||||
| Wound Healing | |||||
| 2 | More general conditions related to this trial | ||||
| Eye Diseases | |||||
| Ocular Hypertension | |||||
| 3 | Interventions listed in this trial | ||||
| 5 Fluorouracil with hyaluronic acid | |||||
| 5 Fluorouracil | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Fluorouracil | |||||
| Hyaluronic Acid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adjuvants, Immunologic | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Singapore National Eye Centre | |||||
| Singapore Eye Research Institute | |||||
| Nanchang University | |||||